Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
4.290
+0.790 (22.57%)
At close: Nov 9, 2026, 4:00 PM EST
4.200
-0.090 (-2.10%)
Pre-market: Nov 10, 2026, 7:32 AM EST

LENZ Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
135501794---
Market Cap Growth
-81.25%-36.94%----
Enterprise Value
-62299578---
Last Close Price
4.2916.0028.87---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.9126.23----
PB Ratio
0.701.763.89---
P/TBV Ratio
0.701.763.89---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-15.69----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.01-
Net Debt / Equity Ratio
-1.02-1.02-1.02-1.27-1.19-1.07
Net Debt / EBITDA Ratio
1.323.213.550.904.222.74
Net Debt / FCF Ratio
1.544.173.471.0810.713.39
Asset Turnover
0.060.07--0.46-
Quick Ratio
11.2613.9120.193.554.6814.61
Current Ratio
11.6614.2320.363.634.9114.62
Return on Equity (ROE)
-72.69%-33.63%-38.94%-157.61%-39.80%-
Return on Assets (ROA)
-44.50%-21.86%-25.64%-77.17%-20.07%-
Return on Capital Employed (ROCE)
-78.00%-32.00%-28.60%-139.70%-28.00%-39.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-104.43%-16.40%-6.27%---
FCF Yield
-94.74%-13.98%-7.54%---
Buyback Yield / Dilution
-12.13%-35.39%-986.27%79.28%-1.05%-
SEC Filings: 10-K · 10-Q